Conflict of interest disclosures
Pedro Cahn has received grant support from ViiV and Receipt of honorariaor consultation fees: ViiV – Merck
Bonaventura Clotet is a scientific advisor to two spin-offs: Aelix Therapeutics SL and AlbaJuna Therapeutics SL.
Eugènia Negredo has received honoraria or consultation fees from Merck Sharp & Dohme Corp., ViiV Healthcare, and Janssen; and has participated in a sponsored speaker’s bureau by Merck Sharp & Dohme Corp., ViiV Healthcare, and Janssen.
Omar Sued in Fundación Huésped has received grant support from ViiV, Richmond and Roemmers for Inv. Initiated Research. Participated in advisory
boards for ViiV, Gador and Roche.